What is Bionik Laboratories Corp. (BNKL) stock price today?

Bionik Laboratories Corp. (BNKL) is currently trading at $0.00.

What is BNKL P/E ratio?

Bionik Laboratories Corp.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is BNKL return on equity (ROE)?

Bionik Laboratories Corp.'s return on equity (ROE) is 250.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Bionik Laboratories Corp.'s market cap?

Bionik Laboratories Corp. has a market capitalization of $1248.

OTC · Medical - Care Facilities

Bionik Laboratories Corp. (BNKL) Stock

$0.00 OTC: BNKL Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$1248
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.72
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	250.00%
ROA	-166.67%
ROCE	-458.24%
Gross Margin	-250.00%
Operating Margin	-250.00%
Net Margin	-250.00%
Debt/Equity	-1.00
Current Ratio	1.50

Annual Financials (USD)

Metric	2019	2020	2021	2022	2023
Revenue	$3.0M	$2.0M	$1.0M	$1.0M	$2.0M
Operating Profit	$-7.0M	$-11.0M	$-6.0M	$-5.0M	$-5.0M
Net Profit	$-11.0M	$-25.0M	$-14.0M	$-10.0M	$-5.0M
EPS	$-4.47	$-5.60	$-2.66	$-1.78	$-0.72
Op Margin	-224.6%	-522.3%	-515.8%	-374.7%	-267.3%

Balance Sheet (USD)

Metric	2019	2020	2021	2022	2023
Total Assets	$31.0M	$19.0M	$9.0M	$5.0M	$3.0M
Total Liabilities	$3.0M	$5.0M	$6.0M	$2.0M	$5.0M
Cash	$0	$2.0M	$1.0M	$2.0M	$0
Borrowings	$0	$2.0M	$4.0M	$0	$2.0M

Cash Flow (USD)

Metric	2019	2020	2021	2022	2023
Operating Cash Flow	$-9.0M	$-9.0M	$-5.0M	$-4.0M	$-3.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$11.0M	$0	$0	$0
Net Cash Flow	$0	$2.0M	$-2.0M	$1.0M	$-2.0M
Free Cash Flow	$-9.0M	$-9.0M	$-5.0M	$-4.0M	$-3.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-0.42
FCF Yield	-271419.39%
Quick Ratio	0.75
Interest Coverage	-45.03
Return 1Y	0.00%
Return 3Y	-99.97%
Return 5Y	—

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About Bionik Laboratories Corp.

Bionik Laboratories Corp. operates as a robotics firm, focusing on the innovation, development, and market introduction of advanced solutions for physical rehabilitation, prosthetic devices, and assistive robotics. The company's product range features the InMotion Robots, a comprehensive collection of robotic therapy tools. This includes the InMotion ARM, an intelligent and interactive therapeutic system grounded in scientific evidence, adept at perceiving patient movements and physical restrictions. Additionally, the InMotion ARM/HAND is offered to facilitate therapies requiring reaching with grasping and releasing actions, alongside individual hand manipulations. Rounding out their offerings is the InMotion Connect platform, which integrates a hardware unit that interfaces with an InMotion Robot, coupled with a subscription for the InMotion Connect Pulse service. Established in 2010, Bionik Laboratories Corp. maintains its principal operations in Watertown, Massachusetts.

Bionik Laboratories Corp. (BNKL) stock trades at $0.00 with a market capitalization of $1248. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Bionik Laboratories Corp. generates a return on equity (ROE) of 250.00% — well above the market average, a sign of a high-quality business, return on capital employed of -458.24%, an operating margin of -250.00%, a net profit margin of -250.00%.

Official website: www.bioniklabs.com